Vocabria (cabotegravir) is a brand-name antiviral medication used to treat or help prevent human immunodeficiency virus (HIV) infection in certain adults and teens. It’s usually taken by mouth for a short time before switching to a long-acting injection — either Cabenuva (cabotegravir / rilpivirine) for treatment or Apretude (cabotegravir) for pre-exposure prophylaxis (PrEP) to lower your risk of HIV infection. For treatment, you take one tablet daily with Edurant (rilpivirine). Common side effects include headache, nausea, and diarrhea.
Vocabria (cabotegravir) is an integrase inhibitor. It works by blocking an enzyme (protein) called integrase that HIV uses to insert its genetic material into your cells. By stopping this step, the medication helps prevent the virus from growing and spreading, lowering the amount of HIV in your body.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
HIV treatment:
HIV PrEP:
HIV treatment:
HIV PrEP:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
HIV treatment:
HIV PrEP:
Yes, Vocabria (cabotegravir) is FDA approved for short-term HIV pre-exposure prophylaxis, also called PrEP. This means it can help lower your risk of getting HIV from sex before you're exposed to the virus. You take it by mouth for a short time — usually about one month — before switching to long-acting Apretude (cabotegravir) injections. Your care team will test you for HIV before starting this medication to make sure it’s safe for you.
You take Vocabria (cabotegravir) by mouth for about a month before starting Apretude (cabotegravir) or Cabenuva (cabotegravir / rilpivirine) to make sure your body can handle the injections. Starting with the tablet form helps your prescriber check for any side effects. After that, you can switch to the injections and stop the pills — unless you need to temporarily replace a missed injection. In that case, your prescriber might have you take Vocabria (cabotegravir) again until you can get back on schedule. If you have questions about switching from the tablets to the injections, talk with your prescriber.
Talk to a healthcare professional about how you can get Vocabria (cabotegravir). It's only available with a prescription, and pharmacists in some states might be able to prescribe it. There are also programs that can also help you pay for and find PrEP medications like Vocabria (cabotegravir).
Weight gain wasn't a commonly reported side effect in people taking Vocabria (cabotegravir) during clinical studies. If you have any questions or concerns about weight gain with this medication, talk to your prescriber.
Vocabria (cabotegravir) hasn’t been well-studied in people during pregnancy, but it's generally recommended in pregnancy when needed. In addition, research on the injectable form of this medication showed that it's safe to take before and during pregnancy. If you're pregnant while taking Vocabria (cabotegravir), you’re encouraged to enroll in the Antiretroviral Pregnancy Registry (APR). This registry tracks the health of you and your baby. You can learn more by calling 1-800-258-4263.
It's not clear if Vocabria (cabotegravir) is safe while breastfeeding, but animal studies show that the medication can pass into breast milk. If you have HIV, feeding your baby with formula or donor breast milk is the safest way to avoid passing the virus to your baby. But if you choose to breastfeed, discuss with your prescriber about the risks of taking this medication while nursing. Even if you’re taking Vocabria (cabotegravir) for HIV prevention (PrEP), your breastfed baby could still have side effects from the medication.
Vocabria (cabotegravir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Vocabria (cabotegravir) might not always fully prevent HIV infection, so it’s important to use other ways to protect yourself too. This includes practicing safer sex (like using condoms), knowing your partner’s HIV status, and getting tested regularly for HIV and other STIs. Taking Vocabria (cabotegravir) on time every day helps lower your chance of getting HIV.
Before starting Vocabria (cabotegravir), your prescriber might ask you about any recent situations where you could have been exposed to HIV — like unprotected sex or a recent STI. You'll also need to take an HIV test. Let your prescriber know if you have symptoms of HIV, such as fever, feeling tired, muscle pain, and skin rash, either before or during treatment.
Some people have had serious allergic reactions while taking cabotegravir, the active ingredient in Vocabria (cabotegravir). In rare cases, these reactions have included serious skin problems like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). That's why you start with Vocabria (cabotegravir) tablets — to help catch any reaction before switching to long-acting injections. Stop taking the medication right away and call your care team if you get a severe rash or a rash with other symptoms like fever, feeling very tired, muscle or joint pain, blisters, mouth sores, red or irritated eyes, facial swelling, or trouble breathing.
Rarely, Vocabria (cabotegravir) can cause serious liver problems. Your risk might be higher if you’ve had liver problems before. Talk to your care team about your medical history before starting this medication so they can decide if it's safe for you to take.
You might need regular blood tests while taking Vocabria (cabotegravir) to check your liver health. Call your prescriber right away if you notice signs of liver problems like pain in the upper right side of your stomach, yellowing of your skin or eyes, dark urine, pale stools, nausea, vomiting, loss of appetite, or itching.
Some people have experienced mood changes, including depression, mood swings, and suicidal thoughts of behavior while taking Vocabria (cabotegravir). If you or someone close to you notices any changes in your mood, call your prescriber right away. They will help decide if it’s safe for you to keep taking Vocabria (cabotegravir).
Vocabria (cabotegravir) can interact with many other medications. These interactions can lead to side effects, making the medication not work as it should for treating or preventing HIV, or cause the virus to become harder to treat. Before and while taking Vocabria (cabotegravir), tell your prescriber about everything you take — prescription, over-the-counter products, and supplements — so they can help manage any possible interactions.
Vocabria (cabotegravir) is approved for adults and teens ages 12 and older, weighing at least 35 kg (77 lbs).
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Vocabria (cabotegravir) will not be safe for you to take.